These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12509365)

  • 1. Is treatment of atrial fibrillation in primary care based on thromboembolic risk assessment?
    Rutten FH; Hak E; Stalman WA; Verheij TJ; Hoes AW
    Fam Pract; 2003 Feb; 20(1):16-21. PubMed ID: 12509365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
    Tomlin AM; Lloyd HS; Tilyard MW
    Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.
    Hsu JC; Chan PS; Tang F; Maddox TM; Marcus GM
    Am J Med; 2015 Jun; 128(6):654.e1-654.e10. PubMed ID: 25554371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary feedback to improve prescribing.
    Elliott RA; Woodward MC; Oborne CA
    Age Ageing; 2002 Sep; 31(5):391-6. PubMed ID: 12242203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
    Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
    Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
    Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
    Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
    JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and adherence to guidelines of antithrombotic therapy in Thai patients with nonvalvular atrial fibrillation.
    Jedsadayanmata A
    J Med Assoc Thai; 2013 Jan; 96(1):91-8. PubMed ID: 23720984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentré F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Therapie; 2000; 55(6):681-9. PubMed ID: 11234463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentre F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Cerebrovasc Dis; 2001; 12(3):245-52. PubMed ID: 11641591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. From scientific evidence to practice.
    Osseby GV; Benatru I; Sochurkova D; Urbinelli R; Megherbi SE; Couvreur G; Moreau T; Wolf J; Giroud M
    Prev Med; 2004 Feb; 38(2):121-8. PubMed ID: 14715203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of thromboembolism in patients with chronic atrial fibrillation in primary health care].
    Martín Acicoya D; Pedrero Pérez P; Martínez García JA; González Alvaro A; Hernando López T; Herreros Hernanz I
    Med Clin (Barc); 2004 Jan; 122(2):53-6. PubMed ID: 14733855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin.
    Hellemons BS; Langenberg M; Lodder J; Vermeer F; Schouten HJ; Lemmens T; van Ree JW; Knottnerus JA
    BMJ; 1999 Oct; 319(7215):958-64. PubMed ID: 10514159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
    Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
    Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.